DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019
18
DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019
Transcript of DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019
DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019
AMBER 1 07:00-08:00
DONNE DERMATOLOGHE ITALIANE: Dermatology and women red face CO-CHAIRS: Corinna Rigoni (ITALY), Norma Cameli (ITALY)
07:00 The Skin aging exposome May El Samahy (EGYPT)
07:10 Periorbital rejuvenation with EBD Eman El Morsy (EGYPT)
07:20 Radiotherapy related dermatoses Nayera Moftah (EGYPT)
07:30 Borderline lepromatous leprosy: Uncommon presentation Elwan Nagwa (EGYPT)
07:35 The lady of the rings Claudia Menicanti (ITALY)
07:40 Burning red face Valentina Benzecry (ITALY)
07:45 Genodermatoses of the face Michela Brena (ITALY)
07:48 Genodermatoses of the face Susanna Bernardon (ITALY)
07:50 Red face in cancer patients Sara Cacciapuoti (ITALY)
07:55 The face of inflammatory diseases Maddalena Napolitano (ITALY)
AMBER 2 07:00-08:00
GRUPPO SIDeMaST DERMATOLOGIA ESTETICA: Threads in aesthetic dermatology CO-CHAIRS: Lucia Brambilla (ITALY), Marina Romagnoli (ITALY)
07:00 Biostimulation with threads: how can we armonize facial features with threads, stem cell and stabilised hybrid co-operative complexes of H-HA and L-HAMarina Romagnoli (ITALY), Rosalba Russo (ITALY)
07:15 Threads for the treatment of acne scars: a new approach Gabriella Fabbrocini (ITALY)
07:30 The right thread for the periocular area Maria Vastarella (ITALY)
07:45 Side effects and how to manage them Anna Masarà (ITALY)
AMBER 3 07:00-08:00
GRUPPO SIDeMaST RICERCA SPERIMENTALE E BIOINGEGNERIA IN DERMATOLOGIA: Research snippets in Immune-Mediated and Oncological diseases CO-CHAIRS: Andrea Chiricozzi (ITALY), Francesca Prignano (ITALY)
07:00 Clinical relevance of the oxidoreductive pathway in chronic dermatological diseases Leonardo Pescitelli (ITALY)
07:08 Discussion
07:10 Clinico-pathological characterization of patients with localized scleroderma and response to UVA-1 phototherapy: in vitro and in vivo skin models Linda Tognetti (ITALY)
07:18 Discussion
07:20 Features of gut microbiota in vitiligo patients Roberta Colucci (ITALY)
07:28 Discussion
07:30 Genetic susceptibility in pediatric melanoma Cristina Pellegrini (ITALY)
07:38 Discussion
07:40 Phenotypical characterization of immune cells associated with histological regression in cutaneous melanoma Simone Ribero (ITALY)
07:48 Discussion
07:50 Molecular characterization of in-transit melanoma metastases and circulating melanoma cells recognizes an expression panel potentially related to disease progression Cristina Rapanotti (ITALY)
07:58 Discussion
AMBER 4 07:00-08:00
GRUPPO SIDeMaST PATOLOGIA DELLE MUCOSE: Diagnostic of pigmentary mucosal lesions CO-CHAIRS: Marco Ardigò (ITALY), Elisa Cinotti (ITALY)
07:00 Oral lesions Vincenzo De Giorgi (ITALY)
07:15 Genital lesions Sabina Vaccari (ITALY)
IS
IS
IS
IS
THURSDAY 13 JUNE, 2019
07:30 Conjunctival lesions Elisa Cinotti (ITALY)
07:45 Confocal microscopy of oral and genital pigmented lesions Marco Ardigò (ITALY)
AMBER 5+6 07:00-08:00
AIDA: Reputation and digital dermatological professional approach CO-CHAIRS: Saturnino Gasparini (ITALY), Domenico Piccolo (ITALY)
07:00 Social Networking Sites: tools for the dermatologist’s communication Federica Osti (ITALY)
07:20 Dermatological internet sites: a source of public health Giovanni Menchini (ITALY)
07:40 The influence of digital media on the dermatologist’s reputation Alessandro Martella (ITALY)
AMBER 7+8 07:00-08:00
ADOI: Classification of Skin Tumors: What’s new? CO-CHAIRS: Cesare Massone (ITALY), Pier Alessandro Fanti (ITALY)
07:00 Updated classification of cutaneous lymphomas Emilio Berti (ITALY)
07:25 Updated classification of melanocytic tumors Lorenzo Cerroni (AUSTRIA)
07:50 Discussion
BROWN 1 07:00-08:00
GRUPPO SIDeMaST STORIA DELLA DERMATOLOGIA E VENEREOLOGIA: History of Dermatology CO-CHAIRS: Cataldo Patruno (ITALY), Valeria Gaspari (ITALY)
07:00 HIV/AIDS in the history of Dermatology and Venereology Luigi Valenzano (ITALY)
07:20 The Salernitan School of Medicine, pioneer of the modern medical and dermatologic science Massimo Nacca (ITALY)
07:40 The Hospital of Santa Maria of the Incurables in Naples, Italy: Its Role in the History of Dermatology Patrizia Forgione (ITALY)
AMBER 1 08:00-10:45
Pemphigoid Diseases CHAIR: Luca Borradori (SWITZERLAND) CO-CHAIRS: David Woodley (UNITED STATES), Wataru Nishie (JAPAN)
08:00 Epidemiology and associations Li Li (CHINA)
08:25 Clinical spectrum and presentations of the pemphigoid group of diseases Janet Fairley (UNITED STATES)
08:50 Pathophysiology Wataru Nishie (JAPAN)
09:15 Diagnostic algorithm for the pemphigoid group of diseases: practical approach Detlef Zillikens (GERMANY)
09:40 Practical management of bullous pemphigoid Luca Borradori (SWITZERLAND)
10:05 Bullous pemphigoid: new therapies on the horizon Frédérick Caux (FRANCE)
10:30 Discussion
AMBER 2 08:00-10:45
Update on Dermatopathology CHAIR: Eduardo Calonje (UNITED KINGDOM) CO-CHAIRS: Philip Leboit (UNITED STATES), Yu-Hung Wu (CHINESE TAIPEI)
08:00 Genodermatoses Dieter Metze (GERMANY)
08:23 Clinicopathological correlation in dermatopathology Eduardo Calonje (UNITED KINGDOM)
08:46 Update in cutaneous lymphoma Reuven Bergman (ISRAEL)
09:09 Patterns of drug eruption Yu-Hung Wu (CHINESE TAIPEI)
09:32 Update in cutaneous mucinosis Franco Rongioletti (ITALY)
09:55 Molecular insights into the nature and diagnosis of melanocytic neoplasms Philip Leboit (UNITED STATES)
IS
IS
IS
SY
SY
THURSDAY 13 JUNE, 2019
10:18 Benign mimics of cutaneous lymphoma Adriana Garcia (SPAIN)
10:41 Q&A - Final discussion
AMBER 3 08:00-10:45
Deep Fungal Infections CHAIR: Rataporn Ungpakorn (THAILAND) CO-CHAIRS: Boni Elizabeth Elewski (UNITED STATES), Nejib Doss (TUNISIA)
08:00 Introduction of speakers
08:05 Mycetoma Nejib Doss (TUNISIA)
08:35 Immunology and future application for deep fungal infections Charussri Leeyaphan (THAILAND)
09:05 Dimorphic mycoses Lauren Kole (UNITED STATES)
09:35 Superficial fungi causing deep mycoses Roderick Hay (UNITED KINGDOM)
10:05 Highlights on histopathological diagnosis of deep fungal infections Dirk Elston (UNITED STATES)
10:35 Q&A and Concluding remarks
AMBER 4 08:00-10:45
FELLOW FORUM 3 CO-CHAIRS: Chun-Wei Lu (CHINESE TAIPEI), Anna Campanati (ITALY)
08:00 Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub Saharan Africa A. S. Akakpo (TOGO)
08:15 Differential diagnosis of palpable lesions: the role of reflectance confocal microscopy and optical coherence tomography F. Garbarino (ITALY)
08:30 Mohs micrographic surgery in Singapore: a retrospective review W. Ho (SINGAPORE)
08:45 Predictive importance of plasma prolidase, adenosine deaminase and dipeptidyl peptidase- 4 as markers of collagen turnover in relation to the skin core in scleroderma H. Cocic (SERBIA)
09:00 A Randomized Controlled Trial of Anti-TNF Alpha Bio-similar Adalimumab versus Prednisolone in the Management of Leprosy Patients with New Type 1 Lepra Reaction D. Mitra (INDIA)
09:15 Adult T-cell leukemia/lymphoma: report of four cases L. Porfirio (BRAZIL)
09:30 Omalizumab versus Cyclosporin-A for the treatment of Chronic Spontaneous Urticaria: is there specific patient characteristics or biomarkers to indicate response to treatment? O. Su Kucuk (TURKEY)
09:45 Punctate palmoplantar keratoderma: characterization of three families with AAGAB mutation R. Pimenta (PORTUGAL)
10:00 Prurigo pigmentosa: a clinicopathologic study of ten Chinese cases LQ W. Wang (CHINA)
10:15 The value of trichoscopy in predicting the treatment outcome in patients with patchy alopecia areata – preliminary results. M. Sikora (POLAND)
10:30 A Patient Survey of photodynamic therapy: experience from two regional services B. Ho (UNITED KINGDOM)
AMBER 5+6 08:00-10:45
New Oral Small Molecules CHAIR: Lone Skov (DENMARK) CO-CHAIRS: Aleksandar Sekulic (UNITED STATES), Brett King (UNITED STATES)
08:00 Introduction
08:10 New Oral Small Molecules for non-melanoma skin cancer Aleksandar Sekulic (UNITED STATES)
08:30 Q&A
08:35 New Oral Small Molecules for melanoma Paola Queirolo (ITALY)
SY
FF
SY
THURSDAY 13 JUNE, 2019
THU
RSD
AY
13 J
UN
E
08:55 Q&A
09:00 New Oral Small Molecules for lupus and related diseases Marzia Caproni (ITALY)
09:20 Q&A
09:25 New Oral Small Molecules for psoriasis Lars Iversen (DENMARK)
09:45 Q&A
09:50 New Oral Small Molecules for atopic dermatitis Thomas Bieber (GERMANY)
10:10 Q&A
10:15 JAK inhibitors in inflammatory skin diseases besides atopic dermatitis and psoriasis Brett King (UNITED STATES)
10:35 Q&A
10:40 Conclusions
AMBER 7+8 08:00-10:45
Photodynamic Therapy CHAIR: Rolf-Markus Szeimies (GERMANY) CO-CHAIRS: Colin Morton (UNITED KINGDOM), Luis Antonio Torezan (BRAZIL)
08:00 Welcome and Introduction Rolf-Markus Szeimies (GERMANY)
08:05 PDT basics Luis Antonio Torezan (BRAZIL)
08:25 PDT for non-melanoma skin cancer Colin Morton (UNITED KINGDOM)
08:45 PDT for actinic keratoses Rolf-Markus Szeimies (GERMANY)
09:05 Discussion
09:15 Aesthetic PDT Nellie Konnikov (UNITED STATES)
09:35 Antimicrobial PDT Yolanda Gilaberte (SPAIN)
09:55 PDT in transplant recipients Stefano Piaserico (ITALY)
10:15 PDT for inflammatory skin disorders Cheng-Che Eric Lan (CHINESE TAIPEI)
10:35 Discussion and Closure of Session
BLUE 1 08:00-10:45
Basic Cosmetic Dermatology CHAIR: Marina Landau (ISRAEL) CO-CHAIRS: Joyce Lim (SINGAPORE), Carlos Wambier (BRAZIL)
08:00 Why dermatologists should take care of cosmetic patients? Marina Landau (ISRAEL)
08:13 The art and science of cosmetic consultation Nancy Garcia Tan (PHILIPPINES)
08:24 Basic surface anatomy relevant for injectors Tatjana Pavicic (GERMANY)
08:35 BtxA – The Dos and Don’ts Doris Hexsel (BRAZIL)
08:46 What dermatologist should know before starting to treat a skin of color? Pearl Grimes (UNITED STATES)
08:57 Dermal fillers – how do I use them in my practice? Gary D. Monheit (UNITED STATES)
09:08 Q&A
09:18 Female intimate rejuvenation: The why, when and how Nicola Zerbinati (ITALY)
09:29 The dark side of dermal fillers – inflammatory and vascular fillers complications: how to avoid and treat Joyce Lim (SINGAPORE)
09:41 Chemical peels – why dermatologists must use them? Carlos Wambier (BRAZIL)
09:53 Energy based devices – what should be our first choices of equipment in treating Caucasians and why? Moshe Lapidoth (ISRAEL)
10:05 Energy based devices – what should be our first choices of the machines in treating Asian patients and why? Chee Leok Goh (SINGAPORE)
10:20 Do we need autologous products for aging prevention and restoration? Martina Kerscher (GERMANY)
10:35 Q&A
SY
CO
THURSDAY 13 JUNE, 2019
BLUE 2 08:00-10:45
Basic Dermatological Surgery CHAIR: Christopher Arpey (UNITED STATES) CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), Andrea Paradisi (ITALY)
08:00 Preoperative Considerations Christian L. Baum (UNITED STATES)
08:15 Critical anatomy pearls/Danger zones Luiz Guilherme Castro (BRAZIL)
08:35 Essentials Instruments/Suture Material Ally-Khan Somani (UNITED STATES)
08:55 Electrosurgery basics Jerry D. Brewer (UNITED STATES)
09:10 Questions
09:20 Local anesthesia tips Myrto-Georgia Trakatelli (GREECE)
09:40 Biopsy Pearls Jenda Ricar (CZECH REPUBLIC)
10:00 Suturing Techniques Andrea Paradisi (ITALY)
10:20 Cryosurgery Paola Pasquali Toledo (SPAIN)
10:35 Questions
BROWN 1 08:00-10:45
Cutaneous Lymphoma: Classification and Management CHAIR: Emilio Berti (ITALY) CO-CHAIRS: Xavier Rueda (COLOMBIA), Youn Kim (UNITED STATES)
08:00 Overview of updates in the WHO classification Emilio Berti (ITALY)
08:20 Updates in molecular pathogenesis and biomarkers in MF/SS Maarten Vermeer (NETHERLANDS)
08:40 Management of early stage mycosis fungoides (MF) Julia Scarisbrick (UNITED KINGDOM)
09:00 Management of Sézary syndrome (SS) Youn Kim (UNITED STATES)
09:20 Experience in NK/T-cell lymphomas Xavier Rueda (COLOMBIA)
09:40 Management of rare CTCLs including SPTCL and G/D TCL Pietro Quaglino (ITALY)
10:00 Approach to management of cutaneous B cell lymphoma Joan Guitart (UNITED STATES)
10:20 Current concepts in CD30+ lymphoproliferative disorders Alessandro Pileri (ITALY)
10:40 Q&A
BROWN 2 08:00-10:45
Bacterial infections of the skin CHAIR: Francisco Bravo (PERU) CO-CHAIRS: Roshidah Baba (MALAYSIA), Alireza Khatami (IRAN)
08:00 Global Burden of bacterial skin infections Alireza Khatami (IRAN)
08:20 Cutaneos tuberculosis Ivonne Arellano Mendoza (MEXICO)
08:40 Buruli ulcer Filippo La Rosa (ITALY)
09:00 Common bacterial infections in outpatients and inpatients Juan Carlos Diez de Medina (BOLIVIA)
09:20 Leprosy Carolina Talhari (BRAZIL)
09:40 Borreliosis Almut Boer (GERMANY)
10:00 Bartonellosis, endemic and cosmopolitan Francisco Bravo (PERU)
10:20 Q&A
BROWN 3 08:00-10:45
Neutrophilic Dermatoses CHAIR: Mark Davis (UNITED STATES) CO-CHAIRS: Alessandro Navarini (SWITZERLAND), Angelo Valerio Marzano (ITALY)
08:00 Neutrophilic diseases: an overview Mark Davis (UNITED STATES)
SY
SY
SY
CO
THURSDAY 13 JUNE, 2019
08:20 Pyoderma gangrenosum Stanislav Tolkachjov (UNITED STATES)
08:40 Sweet’s Syndrome Alex Ortega Loayza (UNITED STATES)
09:00 Syndromic pyoderma gangrenosum and other rarer neutrophilic diseases Angelo Valerio Marzano (ITALY)
09:20 Neutrophilic diseases in childhood Antonio Torrelo (SPAIN)
09:40 Skin and autoinflammation Alessandro Navarini (SWITZERLAND)
10:00 Treatment of neutrophilic diseases Philip Hampton (UNITED KINGDOM)
10:20 Discussion
RED 1+2 08:00-10:45
Dermoscopy of Pigmented Lesions CHAIR: Iris Zalaudek (AUSTRIA) CO-CHAIRS: Allan Halpern (UNITED STATES), Wilhelm Stolz (GERMANY)
08:00 Advances in skin imaging Allan Halpern (UNITED STATES)
08:15 Genes and patterns of melanoma Susana Puig (SPAIN)
08:30 Genes and patterns of nevi Peter Soyer (AUSTRALIA)
08:45 Patients with multiple nevi Iris Zalaudek (AUSTRIA)
09:00 Implementing dermoscopy in everyday practice Petr Arenberger (CZECH REPUBLIC)
09:15 Special anatomic body sites - why and how to manage Wilhelm Stolz (GERMANY)
09:30 Dermoscopy in the treatment decision Aimilios Lallas (GREECE)
09:45 The many faces of seborrheic keratoses Caterina Longo (ITALY)
10:00 Diagnosis and management of congenital melanocytic nevi Ashfaq Marghoob (UNITED STATES)
10:15 Dermoscopy of pigmented lesions Elisa Cinotti (ITALY)
10:30 Q&A
SPACE 1 08:00-10:45
Atopic Eczema: Management CHAIR: Carsten Flohr (UNITED KINGDOM) CO-CHAIRS: Alan Irvine (IRELAND), Giampiero Girolomoni (ITALY)
08:00 When is systemic therapy warranted? Phyllis Spuls (NETHERLANDS)
08:25 The place for conventional systemic therapy in the biologic era Jorien van der Schaft (NETHERLANDS)
08:50 Novel systemic therapies Kenji Kabashima (JAPAN)
09:15 The role of skin infection in AD: when to treat? Claudia Traidl-Hoffmann (GERMANY)
09:40 Manipulation of the host microbiome Tilo Biedermann (GERMANY)
10:05 Treatment of itch Gil Yosipovic (UNITED STATES)
10:30 Discussion
SPACE 2 08:00-10:45
Management of Androgenetic Alopecia CHAIR: George Cotsarelis (UNITED STATES) CO-CHAIRS: Won-Soo Lee (KOREA, REPUBLIC OF), Rodney Sinclair (AUSTRALIA)
08:00 Systemic Causes of Hair Loss Lynn Drake (UNITED STATES)
08:20 Updates on the management of male AGA Won-Soo Lee (KOREA, REPUBLIC OF)
08:40 Post finasteride syndrome Ken Washenik (UNITED STATES)
09:00 Cicatricial Alopecias Wilma Bergfeld (UNITED STATES)
09:20 Break
09:35 Update on Female Pattern Hair Loss Rodney Sinclair (AUSTRALIA)
09:55 Prostaglandins and hair loss George Cotsarelis (UNITED STATES)
10:15 Pathomechanism of permanent hair loss after chemotherapy - priming mobilization and depletion of hair follicle stem cells Ohsang Kwon (KOREA, REPUBLIC OF)
10:35 Q&A
SY
SY
SY
THURSDAY 13 JUNE, 2019
SPACE 3 08:00-10:45
Newly described skin disorders CHAIR: Bruce Thiers (UNITED STATES) CO-CHAIRS: Abdul-Ghani Kibbi (LEBANON), Sunil Kalia (CANADA)
08:00 Introduction Bruce Thiers (UNITED STATES)
08:05 Molecular characterization of disease phenotypes Mark C. Udey (UNITED STATES)
08:25 New pediatric diseases Antonio Torrelo (SPAIN)
08:45 New infectious diseases Omar Lupi da Rosa Santos (BRAZIL)
09:05 New insights into bullous pemphigoid Hideyuki Ujiie (JAPAN)
09:25 Neutrophil-mediated diseases Dany Nassar (LEBANON)
09:45 Syndromic hidradenitis suppurativa John Ingram (UNITED KINGDOM)
10:05 Inherited cancer syndromes with skin manifestations Alexandros Stratigos (GREECE)
10:25 Skin diseases first reported by Chinese dermatologists Jianzhong Zhang (CHINA)
SPACE 4 08:00-10:45
Investigation and Management of Psoriasis Associated Comorbidity CHAIR: Colin Thiam Seng Theng (SINGAPORE) CO-CHAIRS: Paolo Gisondi (ITALY), Christopher Baker (AUSTRALIA)
08:00 How to build an effective Patient-Physician relationship in the setting of psoriasis Christine Bundy (UNITED KINGDOM)
08:20 The role of dermatologist in the management of patients with psoriatic arthritis Paolo Gisondi (ITALY)
08:40 Managing psoriasis in obese patients Peter Foley (AUSTRALIA)
09:00 Do biologics in patients with psoriasis improve cardiovascular risk? Kim Alexander Papp (CANADA)
09:20 Psoriasis Comorbidities - What do the registries tell us Matthias Augustin (GERMANY)
09:40 Psychological impact Francesca Sampogna (ITALY)
10:00 Challenging Cases - Psoriasis with Co-Morbidities Alessandro Giunta (ITALY)
10:20 Q&A
WHITE 1 08:00-10:45
Skin imaging other than dermatoscopy CO-CHAIRS: Agnes Heng (MALAYSIA), Rainer Hofmann-Wellenhof (AUSTRIA)
08:00 Introduction
08:05 Novel technologies to investigate the distribution of facial melanin pigmentation W. Arkesteijn (NETHERLANDS)
08:15 A super-resolution method for skin imaging A. Avanaki (UNITED STATES)
08:25 Resolution of chronic plaque psoriasis with Secukinumab – a 3-dimensional photographic representation R. Sinclair (AUSTRALIA)
08:35 A Deep Learning approach to automatically classify skin inflammation of in vivo confocal images D. Boudier (FRANCE)
08:45 Artificial Intelligence For The Objective Assessment Of Acne Grading In Clinical Trials A. Cherubini (ITALY)
08:55 Reflectance confocal microscopy: a new algorithm to differentiate challenging melanocytic skin lesions R. de Paula Ramos Castro (BRAZIL)
09:05 Differentiation of inflammatory papulosquamous skin diseases based on skin biophysical and ultrasonographic properties: A decision tree model A. Firooz (IRAN)
09:15 Assessment of the Lip Barrier: Microspectroscopic Confocal Raman Spectroscopy and Macroscopic Biophysical Measurements H. Gunt (UNITED STATES)
SY
FC
SY
THURSDAY 13 JUNE, 2019
09:25 Development of Artificial Intelligence based mobile application for ten common dermatological diseases S. Gupta (INDIA)
09:35 Usefulness of videodermoscopy in the diagnosis of demodicosis O. Karadag Kose (TURKEY)
09:45 Ultrasound imaging in skin lesions – a non invasive tool R. Konathan (INDIA)
09:55 Xanthogranulomas and Xanthomas: 23 lesions evaluated by reflectance confocal microscopy A. Lamberti (ITALY)
10:05 Quantification of Change in 3D Face Shape With Ageing Across Different Ethnic Groups P. Matts (UNITED KINGDOM)
10:15 The Impact of Reflectance Confocal Microscopy in Xeroderma Pigmentosum L. Rocha (BRAZIL)
10:25 Utility of High Frequency Ultrasonography (HFUS) in the diagnosis of Nail Diseases S. Tambe (INDIA)
10:35 Cutaneous acute graft-versus-host disease assessment by confocal video microscopy I. Saknite (UNITED STATES)
WHITE 2 08:00-10:05
Medical therapies CO-CHAIRS: Mauro Salvatore Alessandro Alaibac (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF)
08:00 Introduction
08:05 DC-HIL is a novel immune checkpoint and a promising target for treating melanoma and other cancers P. Cruz (UNITED STATES)
08:15 CRISPR/Cas9-homologous recombination mediated correction of Epidermolysis Bullosa Simplex mutations M. Bchetnia (CANADA)
08:25 Extracorporal photopheresis with 5 aminolevulinic acid in patients with chronic graft-versus-host disease – preliminary results from a pilot study E. Christensen (NORWAY)
08:35 The role of Hydroxychloroquine Sulfate (Plaquenil) therapy in eosive oral Lichen Planus Z. Khamaysi (ISRAEL)
08:45 Comparative evaluation of efficacy of intralesional mycobacterium W vaccine versus intralesional measles mumps rubella vaccine versus autoimplantation therapy in cutaneous warts S. Kumar (INDIA)
08:55 The Effect of Omalizumab in Mastocytosis Patients. Prospective double-blind, placebo controlled multicentre study (XOLMA-Study) J. Maul (SWITZERLAND)
09:05 Electrochemotherapy in elderly, nonsurgical, skin malignancies of the Head and Neck patients: clinical outcome and quality of life management A. Bonadies (ITALY)
09:15 Cilostazole as a preferred drug in the treatment of chilblains M. Shishak (INDIA)
09:25 Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human squamous cell carcinoma cell line A431 in vitro and in vivo J. Tang (CHINA)
09:35 Oral itraconazole can down-regulate serum PDGF-A of children with infantile hemangioma Y. Ran (CHINA)
09:45 Efficacy and Safety of Sirolimus in the Treatment of Blue Rubber Bled Nevus Syndrome in Pediatric Patients B. Zhang (CHINA)
09:55 Topical proline therapy in Prolidase deficiency D. P. Thekkinadeth (INDIA)
WHITE 2 10:05-10:45
Epidemiology CO-CHAIRS: Mauro Salvatore Alessandro Alaibac (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF)
10:05 Chemoprophylaxis and immunoprophylaxis in preventing leprosy in patient contacts R. Baskota (NEPAL)
FC
FC
THURSDAY 13 JUNE, 2019
THURSDAY 13 JUNE, 201910:15 Prevalence of Use Of Skin Lightening Agents
Among Participants In A Community Outreach In South-Eastern Nigeria C. Onyekonwu (NIGERIA)
10:25 MC1R variants in childhood and adolescent melanoma: a pooled-analysis from a large worldwide multicenter cohort of patients C. Pellegrini (ITALY)
10:35 Epidemiology of Dry Skin in the General Population M. Augustin (GERMANY)
YELLOW 1 08:00-10:45
Sex hormones and the skin CHAIR: Christos C. Zouboulis (GERMANY) CO-CHAIRS: Mahira El Sayed (EGYPT), Hironobu Sasano (JAPAN)
08:00 The role of sex hormones in wound healing Matthew J. Hardman (UNITED KINGDOM)
08:19 Sexual hormones and pigmentation Mauro Picardo (ITALY)
08:38 Sexual hormones and alopecia: the follicular interplay Catherine M. Stefanato (UNITED KINGDOM)
08:57 The role of metabolic syndrome in female pattern hair loss Mahira El Sayed (EGYPT)
09:16 Role of androgens in sebaceous gland physiology and pathology Hironobu Sasano (JAPAN)
09:35 Hyperandrogenism and acnes Gabriella Fabbrocini (ITALY)
09:54 Menopause, HRT and skin disorders Christos C. Zouboulis (GERMANY)
10:13 Endocrine-disrupting chemicals and skin manifestations Qiang Ju (CHINA)
10:32 Q&A
YELLOW 2 08:00-10:45
Ichthyoses and Keratodermas CHAIR: David Kelsell (UNITED KINGDOM) CO-CHAIRS: Daniel Hohl (SWITZERLAND), Keith Choate (UNITED STATES)
08:00 The ichthyoses: genes and phenotypes Judith Fischer (GERMANY)
08:20 Q&A
08:25 Syndromic ichthyoses: genes and phenotypes Alain Hovnanian (FRANCE)
08:45 Q&A
08:50 Disease pathways and therapeutic approaches in the ichthyoses Amy Paller (UNITED STATES)
09:10 Q&A
09:15 The keratodermas: genes and phenotypes Yang Yong (CHINA)
09:35 Q&A
09:40 Syndromic keratodermas: genes and phenotypes Keith Choate (UNITED STATES)
10:00 Q&A
10:05 Disease pathways and therapeutic strategies in the keratodermas David Kelsell (UNITED KINGDOM)
10:25 Q&A
10:30 The epidermal barrier: what have we learnt, where do we go Daniel Hohl (SWITZERLAND)
10:40 Q&A
YELLOW 3 08:00-10:45
The Future of Antimicrobials CHAIR: Xinghua Gao (CHINA) CO-CHAIRS: Anna Di Nardo (UNITED STATES), Kenshi Yamasaki (JAPAN)
08:00 New antibiotics for acne Seemal Desai (UNITED STATES)
08:25 Antimicrobial peptides at the epithelial interface Yuping Lai (CHINA)
08:45 Antimicrobial peptides and their role in dermal cells Anna Di Nardo (UNITED STATES)
09:05 Antimicrobial peptides in autoimmune diseases Michel Gilliet (SWITZERLAND)
09:25 Antimicrobial peptides in palmoplantar pustolosis Masamoto Murakami (JAPAN)
09:45 Antimicrobial peptides in rosacea Kenshi Yamasaki (JAPAN)
SY
SY
SY
THURSDAY 13 JUNE, 201910:05 Clioquinol, basic and clinical reseach as an
alternative antimicrobial agent Yuping Ran (CHINA)
10:25 Modulation of Staphylococcus epidermidis bioactivity by Malassezia furfur Xinghua Gao (CHINA)
GOLD 11:00-12:30
CO-CHAIRS: Martine Bagot (FRANCE), Matilda Bylaite (LITHUANIA), Christopher Griffiths (UNITED KINGDOM),
Abdul-Ghani Kibbi (LEBANON)
11:00 Generational aspects of life Paul Redmond (UNITED KINGDOM)
11:30 Psoriasis in 2019 Jonathan Barker (UNITED KINGDOM)
11:50 Insights into Skin Function: Lessons Learned from Genodermatoses Leena Bruckner-Tuderman (GERMANY)
12:10 Can a Dermatologist Practice Without Dermoscopy? Giuseppe Argenziano (ITALY)
AMBER 1 14:30-16:30
Mycobacterial infections in the Biologic Era CHAIR: Josè Fernando Barba Gomez (MEXICO) CO-CHAIRS: Domenico Bonamonte (ITALY), Farhad Handjani (IRAN)
14:30 Cutaneous tuberculosis: an update Francisco Bravo (PERU)
14:45 Childhood cutaneous tuberculosis Farhad Handjani (IRAN)
15:00 Diagnosis of cutaneous tuberculosis Eduardo Poletti (MEXICO)
15:15 Cutaneous tuberculosis and HIV infection Archana Singal (INDIA)
15:30 Latent tuberculosis infection in patient with psoriasis taking biologic therapies Omid Zargari (IRAN)
15:45 Skin infections by nontuberculous mycobacteria Domenico Bonamonte (ITALY)
16:00 Atypical Mycobacterial Infections in Mexico Roberto Arenas (MEXICO)
16:15 Discussion
AMBER 2 14:30-16:30
Pitfalls of diagnosis in skin of colour CHAIR: Seemal Desai (UNITED STATES) CO-CHAIRS: Ophelia Dadzie (UNITED KINGDOM), Rashmi Sarkar (INDIA)
14:30 Introduction & Welcome by the Chairs
14:41 Ancillary diagnostic tools Ophelia Dadzie (UNITED KINGDOM)
14:52 Photo protection and Clinical Potpourri Ivonne Arellano Mendoza (MEXICO)
15:03 Psoriasis and its mimickers Seemal Desai (UNITED STATES)
15:14 Disorders of hypo pigmentation and depigmentation Pearl Grimes (UNITED STATES)
15:25 Melasma and Hyperpigmentation Rashmi Sarkar (INDIA)
15:36 Hair and scalp disorders Amy McMichael (UNITED STATES)
15:47 Pitfalls in Skin of Color Aesthetics Sahar Ghannam (CANADA)
15:58 Semiology & grading scales - “one-size does not fit all” Jianzhong Zhang (CHINA)
16:09 Chemical Peels in Skin of Color Carlos Wambier (BRAZIL)
16:20 Q&A
AMBER 3 14:30-16:30
HPV: Warts, Vaccines and Cancer CHAIR: Mihael Skerlev (CROATIA) CO-CHAIRS: Jinhua Xu (CHINA), Antonio Cristaudo (ITALY)
14:30 The global burden of HPV infections and related diseases Electra Nicolaidou (GREECE)
14:45 HPV infection in China: prevalence, research and perspective Hao Cheng (CHINA)
15:00 Anal and oral HPV infection in the male at risk Antonio Cristaudo (ITALY)
15:15 An update on HPV - associated penile and anal dysplastic lesions Arne Wikström (SWEDEN)
WS
WS
WS
PL
15:30 The frustrations and complications of the HPV treatments Suzana Ljubojević Hadžavdić (CROATIA)
15:45 What is really “old” and really “new” in the HPV World? Marco Cusini (ITALY)
16:00 Nine shades of the HPV prophylaxis Mihael Skerlev (CROATIA)
16:15 Discussion
AMBER 4 14:30-16:30
Epidermolysis Bullosa CHAIR: Katsuto Tamai (JAPAN) CO-CHAIRS: Peter Marinkovich (UNITED STATES), Giovanna Zambruno (ITALY)
14:30 Overview of EB diagnosis Jouni Uitto (UNITED STATES)
14:54 Novel EB subtytpes Giovanna Zambruno (ITALY)
15:18 Overview of EB therapy Leena Bruckner-Tuderman (GERMANY)
15:42 Regenerative therapy of EB Katsuto Tamai (JAPAN)
16:06 Molecular therapy of EB Peter Marinkovich (UNITED STATES)
AMBER 5+6 14:30-16:30
Optimising the management of Keloids CHAIR: Greg Goodman (AUSTRALIA) CO-CHAIRS: Ardeshir Bayat (UNITED KINGDOM), Somesh Gupta (INDIA)
14:30 Recent concepts in the Etiology and pathogenesis of keloids Greg Goodman (AUSTRALIA)
14:42 Prevention of keloids Ardeshir Bayat (UNITED KINGDOM)
14:54 Injectable steroids and cytotoxics in the treatment of keloids Christine Dierickx (BELGIUM)
15:06 Lasers and energy based devices in the treatment of keloids Matteo Tretti Clementoni (ITALY)
15:18 Cryotherapy for keloids Somesh Gupta (INDIA)
15:30 Less explored and experimental treatments for keloid Somesh Gupta (INDIA)
15:42 Combining treatments in the treatment of keloids David Ozog (UNITED STATES)
15:54 Panel discussion with cases Greg Goodman (AUSTRALIA)
16:18 Q&A
AMBER 7+8 14:30-16:30
Advances in the Management of Melanoma CHAIR: Alexander Enk (GERMANY) CO-CHAIRS: Susan Swetter (UNITED STATES), Hiroshi Koga (JAPAN)
14:30 New Molecular Techniques for Cutaneous Melanoma Diagnosis Pedram Gerami (UNITED STATES)
14:45 Discussion
14:50 Artificial Intelligence for Cutaneous Melanoma Detection Susan Swetter (UNITED STATES)
15:05 Discussion
15:10 Novel Combination Therapies in Advanced Melanoma Ester Simeone (ITALY)
15:25 Discussion
15:30 New Aspects of Adjuvant Melanoma Treatment Claus Garbe (GERMANY)
15:45 Discussion
15:50 Advanced Imaging Technology in Early Melanoma Detection Peter Soyer (AUSTRALIA)
16:05 Discussion
16:10 Mutations, metastasis and the importance of multidisciplinary management Victoria Mar (AUSTRALIA)
16:25 Discussion
BLUE 1 14:30-16:30
Advanced Cosmetic Dermatology CHAIR: Andrè Braz (BRAZIL) CO-CHAIRS: Abdullah Al Eisa (SAUDI ARABIA), Sue Ellen Cox (UNITED STATES)
WS
WS
WS
CO
THURSDAY 13 JUNE, 2019
14:30 Neuromodulators to the face: how to avoid and to treat the complications Doris Hexsel (BRAZIL)
14:42 Advanced use of Fillers (HA) to the Upper face (Forehead, glabella and temples) Ada Trinidade de Almeida (BRAZIL)
14:54 Advanced use of Fillers (HA) to the Mid-face (Tear trough, Malar, zygoma) Vince Bertucci (CANADA)
15:06 Advanced use of Fillers (HA) to the lips and perioral region Hassan Ibrahim Hassan Galadari (UNITED ARAB EMIRATES)
15:18 Advanced use of Fillers (HA) to the Lower face (Chin, pre-jowl, jaw line, jaw angle) Andrè Braz (BRAZIL)
15:30 Fillers complications, how to manage? Rebecca Fitzgerald (UNITED STATES)
15:42 Neck and Chest (biostimulators + neuromodulators) Dee Anna Glaser (UNITED STATES)
15:54 Use of Fillers to Hands and Body Sue Ellen Cox (UNITED STATES)
16:06 Neuromodulators, 20 years experience in middle east Abdullah Al Eisa (SAUDI ARABIA)
16:18 Q&A
BLUE 2 14:30-16:30
Basic Dermatological Surgery CHAIR: Christopher Arpey (UNITED STATES) CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), Andrea Paradisi (ITALY)
14:30 Excision and common excisional variations Elena Rossi (ITALY)
14:50 Exteriorization techniques Roland Kaufmann (GERMANY)
15:10 Intraoperative considerations Maria Cristina Messina (BRAZIL)
15:30 Questions
15:40 Postoperative management and wound management Miguel Sanchez Viera (SPAIN)
16:00 Common complications and troubleshooting them Christopher Arpey (UNITED STATES)
16:20 Questions
BROWN 1 14:30-16:30
Confocal Microscopy CHAIR: Pascale Guitera (AUSTRALIA) CO-CHAIRS: Caterina Longo (ITALY), Salvador Gonzalez (SPAIN)
14:30 Technique and semiology/pitfall of the beginner Alon Scope (ISRAEL)
14:42 Q&A
14:45 Tips to integrate RCM in the practice flow & when it is worth the time: melanocytic lesions Caterina Longo (ITALY)
14:57 Q&A
15:00 Tips to integrate RCM in the practice flow & when it is worth the time: non-melanocytic lesions Salvador Gonzalez (SPAIN)
15:12 Q&A
15:15 Amelanotic melanoma and differential Pascale Guitera (AUSTRALIA)
15:27 Q&A
15:30 Macules of the face Harald Kittler (AUSTRIA)
15:42 Q&A
15:45 Ex vivo confocal microscopy of the skin- prospective
Susana Puig (SPAIN)
15:57 Q&A
16:00 Vitiligo Surgery and Confocal Steven Tien Guan Thng (SINGAPORE)
16:12 Q&A
16:15 Difficult cases Anthony Rossi (UNITED STATES)
CO
WS
THURSDAY 13 JUNE, 2019
BROWN 2 14:30-16:30
Classification and Management of Panniculitis CHAIR: Mark Pittelkow (UNITED STATES) CO-CHAIRS: Bernhard Zelger (AUSTRIA), Marcello Menta Simonsen Nico (BRAZIL)
14:30 Panniculitis Overview - Classification and Pathology Bernhard Zelger (AUSTRIA)
14:50 Lymphoproliferative Panniculitides Joan Guitart (UNITED STATES)
15:10 Panniculitis of Rheumatic Syndromes Franco Rongioletti (ITALY)
15:30 Lipodermatosclerosis and other sclerosing Panniculitides Tania Philips (UNITED STATES)
15:45 Erythema Induratum Marcello Menta Simonsen Nico (BRAZIL)
16:00 Calciphylaxis-A Unique Thrombosing Panniculitis Rokea El-Azhary (UNITED STATES)
16:15 Alpha-1 antitrypsin and Enzymatic Panniculitides Mark Pittelkow (UNITED STATES)
BROWN 3 14:30-16:30
Facial Rejuvenation: Beyond Fillers and Toxins CHAIR: Fabio Cuiabano (BRAZIL) CO-CHAIRS: Norma Cameli (ITALY), Gary D. Monheit (UNITED STATES)
14:30 Chemical peels - are the “modern” twists on this old standard worthwhile? Gary D. Monheit (UNITED STATES)
14:45 Discussion
14:50 Laser resurfacing - can we get better results without more downtime? Diletta Bonciani (ITALY)
15:05 Discussion
15:10 Photorejuvenation with non ablative lasers and lights - which technologies for which patients? Norma Cameli (ITALY)
15:25 Discussion
15:30 My experience with microneedling - where, when and how to use for best Otavio Macedo (BRAZIL)
15:45 Discussion
15:50 Threads and Sutures – the long and short of it Fabio Cuiabano (BRAZIL)
16:05 Discussion
16:10 The role of injectable lipolysis on the face Shannon Humphrey (CANADA)
16:25 Discussion
SPACE 1 14:30-16:30
Running a Patch Test Clinic CHAIR: Jason Williams (UNITED KINGDOM) CO-CHAIRS: David Cohen (UNITED STATES), Marlene Isaksson (SWEDEN)
14:30 Patch Testing Basics David Cohen (UNITED STATES)
14:50 Patch Testing Readings Jason Williams (UNITED KINGDOM)
15:10 Importance of Data collection and Analysis Francesca Larese (ITALY)
15:30 Optimal clinic support for Patch testing Marlene Isaksson (SWEDEN)
15:50 Special Considerations in Occupational contact dermatitis Adriene Lee (AUSTRALIA)
16:10 Patch Testing in Brazil Ida Duarte (BRAZIL)
SPACE 2 14:30-16:30
Nail Dermoscopy CHAIR: Bianca Maria Piraccini (ITALY) CO-CHAIRS: Luc Thomas (FRANCE), Sergio Hirata (BRAZIL)
14:30 Nail dermoscopy: procedure and signs Michela Starace (ITALY)
14:46 Onychomycosis André Lencastre (PORTUGAL)
14:57 Inflammatory diseases Je ho Mun (KOREA, REPUBLIC OF)
15:08 Non-melanocytic nail tumors Luc Thomas (FRANCE)
15:19 Nail pigmentations Aurora Alessandrini (ITALY)
15:30 Melanocytic nail tumors Bianca Maria Piraccini (ITALY)
WS
WS
CO
WS
THURSDAY 13 JUNE, 2019
15:41 Intraoperative dermoscopy of pigmented nail Sergio Hirata (BRAZIL)
15:52 Intraoperative dermoscopy of unpigmented nail conditions Amelie Boespflug (FRANCE)
16:03 Test your skills! Bianca Maria Piraccini (ITALY)
16:14 Test your skills! Luc Thomas (FRANCE)
SPACE 3 14:30-16:30
Flaps and Grafts CHAIR: Enrique Herrera Acosta (SPAIN) CO-CHAIRS: Richard Motley (UNITED KINGDOM), Mario Puviani (ITALY)
14:30 Planning and executing flaps, technique and principles behind specific flaps Gaston Galimberti (ARGENTINA)
14:43 Planning and executing grafts Jorge Alonso Suarez Perez (SPAIN)
14:56 Lip reconstruction Jean Michael Amici (FRANCE)
15:09 Eyelid reconstruction Richard Motley (UNITED KINGDOM)
15:22 Forehead and scalp reconstruction David Ramirez Moreno (SPAIN)
15:35 Nose reconstruction Mario Puviani (ITALY)
15:48 Ear reconstruction Klaus Eisendle (ITALY)
16:01 Danger zones reconstruction Ramon Pigem (SPAIN)
16:14 Discussion and Q&A
SPACE 4 14:30-15:30
Psoriasis: Can biologics ever be stopped? CHAIR: Brigitte Dréno (FRANCE) DISCUSSANT: Against - Paolo Gisondi (ITALY) For - Phyllis Spuls (NETHERLANDS)
SPACE 4 15:30-16:30
Atopic Dermatitis: Does early, aggressive therapy change the natural history? CHAIR: Omar Lupi da Rosa Santos (BRAZIL) DISCUSSANT: Against - Diamant Thaci (GERMANY), For - Lawrence Eichenfield (UNITED STATES)
WHITE 1 14:30-16:30
Sexually transmitted infections, tropical and humanitarian dermatology CO-CHAIRS: Sergio Di Nuzzo (ITALY), George Sorin Tiplica (ROMANIA)
14:30 Diagnosis and identification by PCR-RFLP of leishmania species isolated from patients with
cutaneous leishmaniasis in Venezuela A. Armand Mijares (VENEZUELA)
14:40 Skin as a mirror of arsenic contamination of ground water: an observational study A. Das (INDIA)
14:50 Collaboration experience between Dermatology Unit and Infectious Disease Clinic in Modena: optimization strategies for HIV, hepatitis and syphilis screening tests F. Di Tullio (ITALY)
15:00 Cutaneous manifestations of the immune reconstitution inflammatory syndrome (IRIS): a case-series M. Fernández-Sánchez (MEXICO)
15:10 A study on clinical and sociodemographic features of Trichomoniasis in symptomatic and asymptomatic female patients attending std clinic using wet mount and culture as diagnostic tool A. Manohar Prasad (INDIA)
15:20 Unusual clinical pictures of old world cutaneous leishmaniasis A. Momeni (IRAN)
15:30 Childhood sexually transmitted diseases P. Mohanty (INDIA)
15:40 Syphilis and leprosy coinfection: a challenging diagnosis A. Maralur Devegowda (INDIA)
15:50 Neglected Tropical Diseases (NTD) or Neglected People Diseases (NPD)? A. Morrone (ITALY)
CN
CN
FC
WS
THURSDAY 13 JUNE, 2019
16:00 Australian Aboriginal and Torres Strait Islander dermatology D. F. Sebaratnam (AUSTRALIA)
16:10 Ultrasonography in Hansen’s disease S. Srinivasan (INDIA)
16:20 Epidemiological and clinical profile Dermatosis at the malian refugees of Goudebou in Burkina Faso K. Yamoussa (MALI)
WHITE 2 14:30-16:30
Urticaria and pruritus CO-CHAIRS: Monica Corazza (ITALY), Roberta Fachini Jardim Criado (BRAZIL)
14:30 Skin lesions, skin care and characteristics of pruritus in patients with uremia undergoing hemodialysis M. Augustin (GERMANY)
14:40 Autoimmune thyroiditis and stress impairs treatment responses to omalizumab in chronic urticaria and patients with angioedema and higher body-mass-index may require longer treatment P. K. Can (TURKEY)
14:50 Pathophysiology of Itch in Atopic Dermatitis: A 3-Dimensional Study of IL-31 and its Receptorsand Cutaneous InnervationT. Cao (SINGAPORE)
15:00 Subscutaneous auto serum therapy in chronic spontaneous urticaria K. V. Godse (INDIA)
15:10 Subcutaneous Autologous Serum Therapy vs. Conventional Intramuscular Autologous Serum Therapy in Chronic Urticaria: A Randomised, Controlled Trial Comparing the Effectiveness and Safety A. Datta (INDIA)
15:20 Treatment of prurigo nodularis with serlopitant: impact on itch and pain S. Ständer (GERMANY)
15:30 Activity during sleep measured by a sheet shaped body vibrometer is correlated with severity of atopic dermatitis in adults: A comparison with wrist actigraphy measurement T. Ebata (JAPAN)
15:40 Interleukin-31 couples itch sensation to inflammation in allergic skin disease M. Fassett (UNITED STATES)
15:50 High levels of ige against tissue factor and thyroglobulin are reduced by omalizumab in chronic spontaneous urticaria G. Genovese (ITALY)
16:00 Evaluation of a low-dose methotrexate added to H1-antihistamines regimen for severe chronic spontaneous urticaria: a phase III, randomized, placebo-controlled trial S. Leducq (FRANCE)
16:10 Effect of Omalizumab Treatment on Disease Activity in Chronic Spontaneous/Idiopathic Urticaria: Results from XTEND-CIU, a Longitudinal Perspective M. Maurer (UNITED STATES)
16:20 More Patients Treated with Ligelizumab are Angioedema-free compared with Omalizumab: Results of a Phase II Clinical Trial M. Wallace (IRELAND)
YELLOW 1 14:30-16:30
Autoimmune dermatoses and adverse drug reactions CO-CHAIRS: Fabrizio Guarnieri (ITALY), Mariano Suppa (BELGIUM)
14:30 Female patients with dermatitis herpetiformis showed a reduced diagnostic delay and have higher sensitivity rates at autoantibody testing for celiac disease: a multi-centric Italian study E. Antiga (ITALY)
14:40 Combination of tetracycline with nicotynamide and clobetasol versus prednisone in bullous pemphigoid: a retrospective analysis of 106 patients with long-term follow-up K. Woźniak (POLAND)
14:50 Developing classification criteria for cutaneous dermatomyositis J. S. Concha (UNITED STATES)
15:00 Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease D. Xie (AUSTRALIA)
15:10 Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy. J. Leventhal (UNITED STATES)
FC
FC
THURSDAY 13 JUNE, 2019
15:20 Prospective HLA-B*13:01 screening to prevent dapsone hypersensitivity syndrome H. Liu (CHINA)
15:30 Implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy G.E. Molina (UNITED STATES)
15:40 Validating the BIOCHIP and interrater reliability in bullous pemphigoid and pemphigus patients A. Yang (AUSTRALIA)
15:50 Cutaneous side effects in the settings of hematologic patients treated with Ibrutinib A. Pileri (ITALY)
16:00 Do oro-pharyngeal symptoms correlate with endoscopic findings in patients with pemphigus vulgaris? M. Bohdanowicz (UNITED STATES)
16:10 Clinical response to JAK inhibition in patients with familial chilblain lupus and TREX1 mutation C. Günter (GERMANY)
16:20 Major Psychological Complications and Decreased Health-Related Quality of Life among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis R. P. Dodiuk-Gad (CANADA)
YELLOW 2 14:30-16:30
Dermatopathology CO-CHAIRS: Carlo Francesco Tomasini (ITALY), Maria Eugenia Mazzei (URUGUAY)
14:30 Sub Corneal Pustular Dermatoses - A clinicopathological study of 15 patients V. Gopalakrishnan (INDIA)
14:40 Hand foot mouth disease in adults: the importance of clinicopathological correlation and differential diagnosis J. Kim (AUSTRALIA)
14:50 The contribution of Dermato(patho)logy in the follow-up of Vascularized Composite Tissue Allografts (Hands, Face) J. Kanitakis (FRANCE)
15:00 Cutaneous lymphangitis carcinomatosa of breast cancer: about 5 cases F. Kettani (MOROCCO)
15:10 White lesions in oral cavity: a clinico histopathological insight S. Jaiswal (INDIA)
15:20 Follicular Mycosis Fungoides presenting with Spiky/Keratosis pilaris-like Lesions: An Indolent Clinicopathologic Variant of Follicular Mycosis Fungoides C. F. Tomasini (ITALY)
15:30 Proposal for a staging classification of histopathological findings in Granulomaatous Cheilitis B. Nikam (INDIA)
15:40 SIRT3-dependent mitochondrial dynamic remodeling contributes to oxidative stress induced melanocyte degeneration in vitiligo X. Yi (CHINA)
15:50 Poikilodermatous plaque-like hemangioma: a newly defined entity K. Semkova (UNITED KINGDOM)
16:00 Cutaneous Rosai-Dorfman Disease: a report of eleven cases from China and a review of the literature G. Songmei (CHINA)
16:10 Genital basal cell carcinoma, a different pathogenesis from sun-exposed basal cell carcinoma? A case-control study of 30 cases Y. J. Wang (CHINESE TAIPEI)
16:20 A retrospective analysis of histopathological features of morphea K. D. Rambhia (INDIA)
YELLOW 3 14:30-16:30
Paediatric dermatology, genetics and genodermatoses CO-CHAIRS: Anna Belloni Fortina (ITALY), Jean Kanitakis (FRANCE)
14:30 Evidence of common and differential genetic biomarkers for Ps and PsA R. Cascella (ITALY)
14:40 Iatrogenic skin disorders and related factors in newborn infants Z. Csoma (HUNGARY)
14:50 International survey on neonate hygiene and skin care in Neonatal Intensive Care Units (NICUs) C. de Belilovsky (FRANCE)
15:00 Insight into Lichen Planus: A retrospective analytical study of clinical, histopathological profile and treatment response of 1872 patients over 22 years from North India – A Single Centre Experience D. Daulatabad Garg (INDIA)
FC
FC
THURSDAY 13 JUNE, 2019
15:10 Skin manifestations in paediatric patients treated with TNF-Alpha inhibitor for inflammatory bowel disease: a retrospective study A. Genois (CANADA)
15:20 Novel Surgical Approach for Management of Cutaneous Neurofibroma in Neurofibromatosis Type 1 L. Le (UNITED STATES)
15:30 A rare cause of recurrent leg ulcers, identified by a novel mutation in PEPD gene: prolidase deficiency E. Kiratli Nalbant (TURKEY)
15:40 Kindler's syndrome, a clinical, genetic and laboratory study of 210 cases in Panama, 1986 2017 H. Penagos (PANAMA)
15:50 Hair cross sectioning in uncombable hair syndrome: an easy tool for a complex diagnosis V. Piccolo (ITALY)
16:00 Irradiated Human Amniotic membrane Allograft in patients with Dystrophic Epidermolysis Bullosa N. Radwan (EGYPT)
16:10 Localized scleroderma (MORPHEA) in children and adolescents J. Stojkovic-Filipovic (SERBIA)
16:20 Alopecia in Epidermolysis Bullosa: A Systematic Review of Pathogenesis and Clinical Features of Disease D. Xie (AUSTRALIA)
THURSDAY 13 JUNE, 2019
